Neuroprotective effects of a hemoglobin-based oxygen carrier (stroma-free hemoglobin nanoparticle) on ischemia reperfusion injury
Brain Research · 2023-12 · 1821 · 148592
DOI: 10.1016/j.brainres.2023.148592 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain Research, 2023-12. Verfasst von Ryota Tatezawa und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Hokkaido University Graduate School of Medicine, Sapporo, Japan. Hauptthemen laut MEDLINE: Neuroprotective Agents, Reperfusion Injury, Brain Ischemia, Nanoparticles. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science, JSPS.
Abstract (Originalsprache)
The application of hemoglobin (Hb)-based oxygen carriers (HBOCs) to the treatment of cerebral ischemia has been investigated. A cluster of 1 Hb and 3 human serum albumins (Hb-HSA3) was found to exert neuroprotective effects on ischemia/reperfusion injury. Stroma-free hemoglobin nanoparticles (SFHbNP), a subsequently developed HBOC consisting of a spherical polymerized stroma-free Hb core with a HSA shell, contains the natural antioxidant enzyme catalase and, thus, is expected to exert additive effects. We herein investigated whether SFHbNP exerted enhanced neuroprotective effects in a rat transient middle cerebral artery occlusion (tMCAO) model. Rats were subjected to 2-hour tMCAO and divided into the following 3 groups with the intravenous administration of the respective reagents: (1) phosphate-buffered saline (PBS), as a vehicle (2) Hb-HSA3, and (3) SFHbNP. After 24-hour reperfusion, infarct and edema volumes decreased in the order of the PBS, Hb-HSA3, and SFHbNP groups, with a significant difference (p < 0.05) between the PBS and SFHbNP groups. Similar reductions were observed in oxidative stress, leukocyte recruitment, and blood-brain barrier disruption in the order of the PBS, Hb-HSA3, and SFHbNP groups. In the early phase of reperfusion within 6 h, microvascular HBOC perfusion and cerebral blood flow were maintained at high levels during the reperfusion period in the Hb-HSA3 and SFHbNP groups. However, a difference was observed in tissue oxygen partial pressure levels, which significantly decreased after 6-hour reperfusion in the Hb-HSA3 group, but remained high in the SFHbNP group. A superior oxygen transport ability appears to be related to the enhanced neuroprotective effects of SFHbNP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
- Department of Neurosurgery, Hokkaido University Graduate School of Medicine, Sapporo, Japan. Electronic address: cn5t-abmy@asahi-net.or.jp.
- Department of Applied Chemistry, Faculty of Science and Engineering, Chuo University, Tokyo, Japan.
Förderung
- Japan Society for the Promotion of Science
- JSPS
Zitieren
APA
Tatezawa, R., Abumiya, T., Ito, Y., Gekka, M., Okamoto, W., Ishii, K., Kohyama, N., Komatsu, T., & Fujimura, M. (2023). Neuroprotective effects of a hemoglobin-based oxygen carrier (stroma-free hemoglobin nanoparticle) on ischemia reperfusion injury. Brain Research, 1821, 148592. https://doi.org/10.1016/j.brainres.2023.148592
Vancouver
Tatezawa R, Abumiya T, Ito Y, Gekka M, Okamoto W, Ishii K, et al. Neuroprotective effects of a hemoglobin-based oxygen carrier (stroma-free hemoglobin nanoparticle) on ischemia reperfusion injury. Brain Research. 2023;1821:148592. doi:10.1016/j.brainres.2023.148592
BibTeX
@article{Tatezawa2023,
author = {Tatezawa, Ryota and Abumiya, Takeo and Ito, Yasuhiro and Gekka, Masayuki and Okamoto, Wataru and Ishii, Kohta and Kohyama, Natsumi and Komatsu, Teruyuki and Fujimura, Miki},
title = {Neuroprotective effects of a hemoglobin-based oxygen carrier (stroma-free hemoglobin nanoparticle) on ischemia reperfusion injury},
journal = {Brain Research},
year = {2023},
volume = {1821},
pages = {148592},
doi = {10.1016/j.brainres.2023.148592}
}
EUVIMED